Molecular Genetics of Early Neurogenesis
早期神经发生的分子遗传学
基本信息
- 批准号:7574531
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-05-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressApplications GrantsBindingBiological ModelsBone Morphogenetic ProteinsBrainCellsComparative StudyDefectDevelopmental BiologyDiffusionDiseaseDorsalDrosophila genusDrug AddictionDrug abuseEctodermEmbryoFactor AnalysisFutureGene ExpressionGenesGenetic Enhancer ElementGrantHealthHumanInvertebratesMediatingModelingMolecular GeneticsMutateNervous system structureNeuroectodermNeuronsOrthologous GeneOxidative StressPathway interactionsProcessRecyclingRepressionShapesSignal TransductionSourceStagingVertebratesblastomere structurebone morphogenetic protein receptorscell fate specificationchordindopaminergic neurongastrulationgene functionhuman diseasein vivoinsightmorphogensmutantneuroblastneurodevelopmentneurogenesisneuromechanismneuronal patterningprocollagen C-endopeptidaseprogramsrelating to nervous systemresearch studythree dimensional structure
项目摘要
Understanding the mechanism of neural induction in early embryos is a long standing problem in
developmental biology defined by the pioneering experiments of Mangold and Spemann. In the last decade,
endogenous neural inducing substances have been identified in both vertebrate and invertebrate model
systems which function by blocking signaling mediated by the Bone Morphogenetic Protein (BMP)pathway.
BMP signaling acts in the non-neural ectoderm to suppress expression of genes defining the default neural
fate. In the neuroectoderm, antagonists of BMP signaling, including Drosophila Short gastrulation (Sog), and
its vertebrate ortholog Chordin, block this pathway thereby permitting the default neural cell fate program to
prevail. Although the outline of how neural induction is mediated by BMP antagonists is now understood,
several important questions remain. Foremost among these issues are: 1) how are BMP and Sog
morphogen gradients created and stabilized in the context of a rapidly changing embryonic field of cells, and
2) how does a gradient of BMP activity form in the neuroectoderm and how does it interact with other
sources of positional information to subdivide the nervous system into three primary domains expressing
conserved sets of neuroblast identity genes? The overall objective of this grant application is to address
these and related questions in ectodermal patterning and neuronal specification. The Specific Aims are:
1) Analyze mechanisms responsible for creating a dorsal BMP activity gradient
2) Analyze how Dpp contributes to subdividing the neuroectoderm into three territories
The proposed experiments are important to human health. First, the process of neural induction is common
to vertebrates and invertebrates. Consequently, insights gained from the proposed experiments will be
applicable to early stages of human neural development. Second, defects in several genes involved in this
process cause disease when mutated in humans. Also, dopaminergic neurons in the brain of Drosophila are
similarly vulnerable to substances causing oxidative stress, as in humans. Therefore, our comparative
studies in cell fate specification are relevant to using Drosophila as a model for drug addiction. These
studies may provide the framework for our future studies relevant to human disease and drug abuse.
了解早期胚胎神经诱导的机制是一个长期存在的问题
由曼戈尔德和斯佩曼的开创性实验定义的发育生物学。在过去的十年里,
在脊椎动物和无脊椎动物模型中都已鉴定出内源性神经诱导物质
通过阻断由骨形态发生蛋白(BMP)途径介导的信号传导发挥作用的系统。
BMP信号传导在非神经外胚层中起作用,以抑制定义默认神经外胚层的基因的表达。
命运在神经外胚层中,BMP信号传导的拮抗剂,包括果蝇短原肠胚形成(Sog),
它的脊椎动物直系同源物Chordin阻断了这一通路,从而允许默认的神经细胞命运程序,
为准虽然现在已经了解了BMP拮抗剂如何介导神经诱导的概述,
几个重要问题仍然存在。这些问题中最重要的是:1)BMP和Sog如何
在快速变化的胚胎细胞场的背景下产生并稳定的形态发生梯度,以及
2)BMP活性梯度是如何在神经外胚层中形成的,以及它是如何与其他细胞相互作用的?
位置信息的来源,将神经系统细分为三个主要领域,
成神经细胞身份基因的保守序列本补助金申请的总体目标是解决
这些和相关的问题外胚层图案和神经元规格。具体目标是:
1)分析负责创建背侧BMP活性梯度的机制
2)分析Dpp如何将神经外胚层细分为三个领域
拟议的实验对人类健康很重要。首先,神经归纳的过程是共同的
到脊椎动物和无脊椎动物。因此,从拟议的实验中获得的见解将是
适用于人类神经发育的早期阶段。第二,与此相关的几个基因的缺陷,
在人类中发生突变会导致疾病。此外,果蝇大脑中的多巴胺能神经元
同样容易受到氧化应激物质的影响,如人类。因此,我们的比较
细胞命运特化的研究与使用果蝇作为药物成瘾的模型有关。这些
这些研究可为我们日后有关人类疾病和药物滥用的研究提供框架。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETHAN BIER其他文献
ETHAN BIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ETHAN BIER', 18)}}的其他基金
Analysis of homolog-based CRISPR editing in somatic cells
体细胞中基于同源物的 CRISPR 编辑分析
- 批准号:
10343429 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Analysis of homolog-based CRISPR editing in somatic cells
体细胞中基于同源物的 CRISPR 编辑分析
- 批准号:
10676726 - 财政年份:2022
- 资助金额:
$ 33.75万 - 项目类别:
Development of next-generation gene drive technologies for Anopheles population engineering
开发用于按蚊种群工程的下一代基因驱动技术
- 批准号:
10278897 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Development of next-generation gene drive technologies for Anopheles population engineering
开发用于按蚊种群工程的下一代基因驱动技术
- 批准号:
10624305 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Development of next-generation gene drive technologies for Anopheles population engineering
开发用于按蚊种群工程的下一代基因驱动技术
- 批准号:
10408862 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
诱变链式反应:一种自催化基因传播的方法
- 批准号:
10211352 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
诱变链式反应:一种自催化基因传播的方法
- 批准号:
9009589 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
诱变链式反应:一种自催化基因传播的方法
- 批准号:
10395549 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
诱变链式反应:一种自催化基因传播的方法
- 批准号:
10614935 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
Mutagenic chain reaction-facilitated immunotherapy
诱变链式反应促进的免疫疗法
- 批准号:
9163059 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别: